Association study of the GAB2 gene with the risk of developing Alzheimer's disease
Julien Chapuis(Inserm), Jean‐Charles Lambert(Inserm), Emmanuelle Cousin(Sanofi (France)), Thierry Frébourg(Inserm), Alexis Brice(Inserm), Philippe Amouyel(Inserm), Jean‐François Deleuze(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Peter Bentham(Queen Elizabeth Hospital Birmingham), Florence Pasquier(Centre Hospitalier Universitaire de Lille), Didier Hannequin(Hôpital Charles-Nicolle), Uma Thaker(University of Manchester), Isabelle Leber(Inserm), Corinne Lendon(University of Birmingham), Dominique Campion(Inserm), David Mann(University of Manchester)
Cited by 35
Related Papers
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
|The Lancet|2016|4.4k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k